article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Composite Capital Master Fund, and Navistar. per share, raising just over $1 billion for the company. TuSimple's IPO was underwritten by Morgan Stanley, Citigroup and J.P.

Pricing 113
article thumbnail

Techstars Music Names New Class Of Startups In LA

socalTECH

The accelerator said its 2017 and 2018 classes have so far raised more than $40M in follow on investment, with a combined valuation of more than $300M. READ MORE>>.

Class 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How do you pay an early-stage board?

Berkonomics

How do you set the option price? The option price should be set by appraisal under IRS rule 409a, and certainly should be low enough to recognize that common stock options are not worth as much as preferred stock, given the many preferences of the latter.

article thumbnail

Need money? Read this!

Berkonomics

Bootstrapping: This term describes your ability to start a business with little investment and grow it using internally generated funds. You will realize much more from the ultimate sale of your business even if at a considerably lower price than if splitting the proceeds with investors. There is a lot to say about retaining control.

article thumbnail

Why Was Winter in Venture Capital Funding so Short?

Both Sides of the Table

Yet as we enter February 2017 the VC funding markets are booming, Snap, Inc has filed for its IPO, AppDynamics was just purchased for $3.7 But the reality is that “global warming” massively blunted the effects of winter and my prognosis for VC fundings of entrepreneurs in 2017–2018 is now very sunny indeed. Why no winter?

article thumbnail

VelosBio Finds $137M For Oncology Efforts

socalTECH

San Diego-based biopharmaceuticals developer VelosBio says it has raised $137M in a Series B funding roudn, to go towards its oncology efforts. Rowe Price Associates, Inc., Rowe Price Associates, Inc.,

San Diego 113
article thumbnail

Down bad

TechCrunch LA

This week, we saw the interconnectedness of major institutions as crypto lending protocol Celsius stuttered and brought down Ethereum prices with it as investors feared a price collapse brought on by reportedly over-leveraged players like 3 Arrows Capital. I don’t even think digital assets [are] an asset class.